Veru Inc. - Common Stock (NQ:VERU)

2.345 +0.215 (+10.09%)

Delayed Quote Updated: 12:57 PM EDT, Oct 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Veru Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Is It Too Late to Buy Veru Stock? ↗

November 23, 2022

The negative impact of its COVID-19 program faltering will soon be in the past.

Via The Motley Fool

Bragar Eagel & Squire, P.C. Is Investigating Fox, Instil, Veru, and Twist and Encourages Investors to Contact the Firm

November 21, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

Why Shares of Veru Fell 10.33% on Monday ↗

November 21, 2022

Investors are concerned that approval for a COVID-19 therapy will be delayed or denied.

Via The Motley Fool

$100 Invested In Veru 5 Years Ago Would Be Worth This Much Today ↗

November 21, 2022

Via Benzinga

Bragar Eagel & Squire, P.C. Is Investigating Accelerate Diagnostics, and Veru and Encourages Investors to Contact the Firm

November 16, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

Why Veru Stock Is Cratering Today ↗

November 10, 2022

A negative vote on one of its drugs is weighing on the biotech's stock price.

Via The Motley Fool

Why Is VERU Stock Down 50% Today? ↗

November 10, 2022

The regulatory hammer is hitting VERU stock investors hard today as the FDA denies a crucial authorization for Veru's Covid-19 drug.

Via InvestorPlace

VERU ALERT: Bragar Eagel & Squire, P.C. is Investigating Veru Inc. on Behalf of Veru Stockholders and Encourages Investors to Contact the Firm

November 14, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

Why Veru Stock Was Losing One-Third of Its Value This Week ↗

November 11, 2022

The future of a top pipeline drug now looks much dimmer.

Via The Motley Fool

INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Veru Inc. and Encourages Investors with Losses to Contact the Firm

November 11, 2022

From The Schall Law Firm

Via Business Wire

Dow Jumps Over 1,000 Points; Digital Turbine Shares Spike Higher ↗

November 10, 2022

U.S. stocks traded sharply higher toward the end of trading, with the NASDAQ Composite jumping over 6% on Thursday.

Via Benzinga

Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday ↗

November 11, 2022

Gainers

Via Benzinga

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Veru Inc. and Encourages Investors with Losses to Contact the Firm

November 10, 2022

From The Schall Law Firm

Via Business Wire

Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday's Mid-Day Session ↗

November 10, 2022

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions related to the company's...

Via Benzinga

Oracle Layoffs 2022: What to Know About ORCL Job Cuts, Hiring Freeze ↗

November 10, 2022

Oracle (ORCL) layoffs are worth checking out on Thursday as investors keep track of tech companies that are cutting employees.

Via InvestorPlace

Dow Soars Over 900 Points; Nasdaq Over 600 ↗

November 10, 2022

Inflation data for October is sending stocks to the moon today.

Via Talk Markets

Nasdaq Surges 600 Points; Gold Gains 2% ↗

November 10, 2022

U.S. stocks traded sharply higher midway through trading , with the Nasdaq Composite gaining 600 points on Thursday.

Via Benzinga

Cano Health, Vacasa, Organogenesis, And Some Other Big Stocks Moving Lower On Thursday ↗

November 10, 2022

U.S. stocks traded higher, with the Nasdaq surging more than 500 points on Thursday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Dow Jumps Over 700 Points; US Inflation Rate Falls In October ↗

November 10, 2022

U.S. stocks traded sharply higher this morning , following the release of inflation data on Thursday.

Via Benzinga

Veru Stock Plummets 65% After FDA Advisors Vote Down Cancer-Turned-Covid Drug ↗

November 10, 2022

The FDA isn't bound by the advisors' recommendation. But it does consider their vote.

Via Investor's Business Daily

How Is The Market Feeling About Veru? ↗

November 10, 2022

Veru's (NASDAQ:VERU) short percent of float has fallen 12.12% since its last report. The company recently reported that it has 14.69 million shares sold short, which is 22.76% of all regular shares...

Via Benzinga

Veru Stock Could Retrace Week's 45% Gain As FDA Panel Votes Against COVID-19 Drug ↗

November 10, 2022

Veru Inc.

Via Benzinga

Spirit AeroSystems, Oyster Point Pharma, Snap And Other Big Gainers From Monday ↗

November 08, 2022

U.S. stocks closed higher on Monday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

VERU Stock Soars 40% Despite Uncertainty Surrounding Covid-19 Drug ↗

November 07, 2022

While the FDA may have some questions regarding Veru’s Covid-19 therapeutic, investors remain optimistic about VERU stock.

Via InvestorPlace

Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday ↗

November 08, 2022

Gainers

Via Benzinga

Dow Surges 400 Points; Crude Oil Down 1% ↗

November 07, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 400 points on Monday.

Via Benzinga

Medical Leader Veru Catapults As FDA Preps To Discuss Cancer Drug For Covid ↗

November 07, 2022

The company's drug could be used in a specific population of Covid patients.

Via Investor's Business Daily

Veru Shares Jump Over 40% Despite FDA Staff Raises Uncertainties Over Its COVID-19 Therapy ↗

November 07, 2022

Veru Inc (NASDAQ: VERU) is set to face an FDA Advisory Committee meeting on Wednesday regarding its emergency use authorization (EUA) application for the oral COVID-19 therapy sabizabulin.

Via Benzinga

Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session ↗

November 07, 2022

Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.

Via Benzinga

$100 Invested In Veru 5 Years Ago Would Be Worth This Much Today ↗

November 07, 2022

Veru (NASDAQ:VERU) has outperformed the market over the past 5 years by 56.49% on an annualized basis producing an average annual return of 64.35%. Currently, Veru has a market capitalization of $1.22...

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.